Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. MASSAADMASSADE L; CHOUAIB S; GOUYETTE A
   PHENOBARBITAL PREVENTS THE INHIBITORY EFFECTS OF TUMOR-NECROSIS-FACTOR ON GLUTATHIONE-S-TRANSFERASE-MU IN PRIMARY CULTURE RAT HEPATOCYTES
   Anticancer research
   
   L. Massaadmassade et al., "PHENOBARBITAL PREVENTS THE INHIBITORY EFFECTS OF TUMOR-NECROSIS-FACTOR ON GLUTATHIONE-S-TRANSFERASE-MU IN PRIMARY CULTURE RAT HEPATOCYTES", Anticancer research, 18(3A), 1998, pp. 1833-1838
2. MASSAADMASSADE L; DOMENGE C; RONGEAT S; HASSOUN L; LEGROS MH; ROPERS J; JANOT F; PARISE O; GOUYETTE A
   RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/
   Anticancer research
   
   L. Massaadmassade et al., "RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/", Anticancer research, 18(1A), 1998, pp. 283-288
3. MASSAADMASSADE L; RIBRAG V; MARIE JP; FAUSSAT AM; BAYLE C; DREYFUS F; GOUYETTE A
   GLUTATHIONE SYSTEM, TOPOISOMERASE-II LEVEL AND MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOGENOUS LEUKEMIA BEFORE TREATMENT AND AT RELAPSE
   Anticancer research
   
   L. Massaadmassade et al., "GLUTATHIONE SYSTEM, TOPOISOMERASE-II LEVEL AND MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOGENOUS LEUKEMIA BEFORE TREATMENT AND AT RELAPSE", Anticancer research, 17(6D), 1997, pp. 4647-4651